Key result
ASHP framework identifies ~2x more medication therapy problems than PQA in older home health COPD patients.
Why the study?
To identify, characterize, and compare the quantities and categories of medication therapy problems in older adults with COPD requiring home health care after hospital discharge.
Does the ASHP framework identify more medication therapy problems than the PQA framework in older adults with COPD discharged to home health care?
Does the ASHP framework identify more medication therapy problems than the PQA framework in older adults with COPD discharged to home health care?
The ASHP framework may be more sensitive than the PQA framework for identifying medication therapy problems in older adults with COPD transitioning to home health care.
Answers are grounded in this paper and cite their sources.
May improve MTP detection sensitivity in post-discharge COPD home care; leaves open prospective validation of frameworks.
Background Almost 900,000 patients in the United States living with chronic obstructive pulmonary disease (COPD) require home health care each year. Pharmacists are integral members of the home health care team, especially for older adults living with COPD, because of their expertise in identifying and resolving medication therapy problems (MTPs) during transitions of care. Objective To identify, characterize, and compare the quantities and categories of MTPs in older adults living with COPD who require home health care following hospital discharge. Methods This cross-sectional study involved adults aged 65 years and older living with COPD who were discharged from an academic medical center between June 1, 2023, and November 30, 2023. MTPs were classified using two frameworks: the American Society of Health-System Pharmacists (ASHP) and the Pharmacy Quality Alliance (PQA). Results During the study period, 535 older adults were prescribed home health care, 15 of whom had a hospitalization discharge diagnosis of COPD and were screened for inclusion. Among the 13 patients eligible for inclusion, 92.3% experienced one or more MTPs. Almost 80% of the identified MTPs involved issues related to medication indication: 50% of this cross-sectional cohort were not prescribed medications when clinically indicated, and up to 40% of patients were prescribed medications without apparent indications. The ASHP framework identified more than twice the number of MTPs compared to the PQA framework. Conclusion The ASHP framework may identify more MTPs than the PQA framework in older adults living with COPD who require home health care upon discharge. Further research evaluating pharmacist interventions related to MTPs would be beneficial across diverse settings and patient populations.
No takes yet. Share an insight, caveat, or question.
North et al. (2026) studied this question. The ASHP framework identified more than twice the number of medication therapy problems compared to the PQA framework in older adults with COPD requiring home health care.
Synapse has enriched 10 related papers. Consider them for comparative context: